4-(4-Methoxybenzyloxy)-1,3-butanediol>95.0%(GC)5g

2-Methyl-4,6-dimethoxypyrimidine, 97.0%, 100g

(S)-10-Amino-4-ethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 95.0%, 50mg

3-(Methylamino)cyclobutanol, 95.0%, 5g

2-Chloro-5-(isobutyramidomethyl)benzoic acid, 98%, 250mg

2,2,6,6-Tetramethylpiperidine 1-Oxyl Free Radical (purified by sublimation)>99.0%(GC)(T)5g

Solfato di stagno(II), min 99%, pa, 100 g, confezione in plastica.

(S)-1-(2,3-Dihydro-1H-inden-5-yl)ethan-1-amine, 97%, 100mg

1-METHYL-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1H-INDAZOLE, 95.0%, 100g

(S)-1-Amino-2,3-dihydro-1H-indene-4-carbonitrile hydrochloride, 97%, 250mg

2-(piperidin-1-yl)-3-(trifluoromethyl)benzonitrile, 250mg

Methyl (4-cyanophenyl)acetate, 95.0%, 250mg

5,6-Difluoroisoindoline hydrochloride, 97%, 5g